Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microfluidic arrays in genetic analysis.

M T Cronin1, E S Mansfield

  • 1Applied Genomics R&D, ACLARA BioSciences, Inc., 1288 Pear Ave., Mountain View, CA 94043, USA. mcronin@aclara.com

Expert Review of Molecular Diagnostics
|March 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-permeability Relationships for Transcorneal Penetration.

Alternatives to laboratory animals : ATLA·2014
Same author

A quantitative structure-activity relationship (QSAR) investigation of a Draize eye irritation database.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Quantitative structure-Activity relationship (QSAR) analysis of the acute sublethal neurotoxicity of solvents.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

Computational methods for the prediction of drug toxicity.

Current opinion in drug discovery & development·2009
Same author

Prediction models for eye irritation potential based on endpoints of the HETCAM and neutral red uptake tests.

In vitro & molecular toxicology·2002
Same author

The use of pH measurements to predict the potential of chemicals to cause acute dermal and ocular toxicity.

Toxicology·2001
Same journal

Navigating PD-L1 testing in immuno-oncology: analytical robustness, clinical validation, and the role of the VENTANA SP263 assay.

Expert review of molecular diagnostics·2026
Same journal

Extracellular vesicles as diagnostic and prognostic biomarkers in non-small cell lung cancer.

Expert review of molecular diagnostics·2026
Same journal

Explainable epigenetic aging clocks: an overview of existing AI models and approaches.

Expert review of molecular diagnostics·2026
Same journal

Neuro-axonal injury biomarker serum neurofilament light chain is associated with osteoarthritis: a dual-cohort study from NHANES and UK Biobank.

Expert review of molecular diagnostics·2026
Same journal

Diagnostics and novel laboratory approaches to combat <i>Neisseria gonorrhoeae</i> antimicrobial resistance.

Expert review of molecular diagnostics·2026
Same journal

Fluid biomarkers in cerebral amyloid angiopathy: current limitations and future directions.

Expert review of molecular diagnostics·2026
See all related articles

Genetic analysis identifies markers for managing health outcomes. Advancements in data and technology, including microfluidic arrays, are making genetic testing more accessible and routine.

Area of Science:

  • Genetics
  • Bioinformatics
  • Medical Diagnostics

Background:

  • Genetic analysis aims to find markers for predicting phenotypic outcomes with high confidence.
  • Increasingly available consensus sequence data, polymorphism databases, and phenotype data enhance genetic analysis utility.
  • Genetic analysis is becoming more mainstream due to data accessibility and improved predictive value.

Purpose of the Study:

  • To highlight the evolving landscape of genetic analysis.
  • To discuss the role of emerging technologies in routine genetic analysis.
  • To emphasize the importance of genetic markers in managing phenotypic outcomes.

Main Methods:

  • Review of current genetic analysis techniques and platforms.
  • Discussion of data acquisition and interpretation processes.

Related Experiment Videos

  • Exploration of technological advancements like automation, integration, and miniaturization.

    • Main Results:

    • Genetic analysis is becoming more mainstream and useful.
    • Technological maturation is leading to increased automation and integration.
    • Microfluidic arrays are emerging as key components in integrated analytical platforms.

    Conclusions:

    • Genetic analysis is crucial for managing phenotypic outcomes.
    • Technological advancements are simplifying and integrating genetic analysis.
    • Microfluidic arrays are poised to become integral to routine genetic analysis.